News

Shield Therapeutics plc announces top-line results from its AEGIS-CKD pivotal Phase III study of Feraccru. Feraccru is a novel oral ferric iron therapy that has been approved and…
Read More...

Teva Pharmaceutical announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for fremanezumab, an anti-calcitonin gene-related…
Read More...

Allergan plc announced that Matthew M. Walsh has been appointed Executive Vice President and Chief Financial Officer. He will formally join Allergan later this month following a…
Read More...

International contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, Cobra Biologics and Symbiosis Pharmaceutical Services asserted having clinched…
Read More...

Anika Therapeutics integrated orthopedic medicines company based on its proprietary hyaluronic acid ("HA") technology, today announced an agreement with the Institute of Integrative…
Read More...

Biopharmaceutical company focused on developing Western drug candidates in China and North Asia, CANbridge Life Sciences undertakes licensing agreement to develop and commercialize…
Read More...

As U.S is facing the wrath of flu that has become widespread in U.S, FDA continues to oversee this situation closely. FDA Commissioner, Scott Gottlieb vows to take steps to curb saline…
Read More...

The coalition, known as the National Conference of Pharmaceutical Organizations (NCPO), and American Pharmacists Association (APhA) issued a public statement seeking support from the…
Read More...

Select Medical Holdings Corporation and Dignity Health asserted the completion of the transaction to combine Concentra Group with U.S HealthWorks, Inc, a subsidiary of Dignity Health …
Read More...

Clinical-stage pharmaceutical company, Imago BioSciences developing novel therapies for hematological and inflammatory diseases asserted FDA's acceptance of their Investigational New…
Read More...

Allergan plc asserted that the U.S Food and Drug Administration has approved Allergan's  supplemental New Drug Application to augment the use of AVYCAZ (ceftazidime and avibactam) to…
Read More...

With a view to permit cancer patients access to potentially life-saving treatments, Lazarex Cancer Foundation's push for FDA issuing new FDA guidelines was taken into account by the…
Read More...

Clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, Syndax Pharmaceuticals ventured into new Clinical collaboration with AstraZeneca to…
Read More...

Panacea Pharmaceuticals, a clinical stage bio-pharmaceutical company developing novel biologically--targeted cancer therapies and diagnostics declared the enrollment of patient in an…
Read More...

Yunnan Fuwai Hospital declares successful completion of clinical case of MitralStitch mitral valve repair system. The operation was jointly conducted by the team of Professor Pan…
Read More...

It is noteworthy that TVA Medical's everlinQ endoAVF System exhibited positive Clinical results using the everlinQ endoAVF System. An international meta-analysis of clinical experience…
Read More...

Ambry Genetics and Invicro partner to offer customized genomics and imaging services for the pharmaceutical and biotechnology industry, exhibiting profound emphasis on Oncology and…
Read More...

FDA permits a Phase II Clinical Trial in 60 stroke patients, NuvOx Pharma announced FDA approval to proceed to test its investigational drug product, dodecafluoropentane emulsion…
Read More...

In a strategic merger revelation, Seattle Genetics and Cascadian Therapeutics signed a definitive merger agreement under which Seattle Genetics has conceded to acquire Cascadian…
Read More...

Developer of novel surgical tools to enhance a surgeon's ability to perform minimally invasive orthopedic procedures, Ceterix Orthopedics declared completion of enrollment in STITCH…
Read More...